Showing 641-650 of 1119 results for "".
- CollPlant Achieves Milestone in Dermal Filler Developmenthttps://modernaesthetics.com/news/collplant-achieves-milestone-in-dermal-filler-development/2473431/CollPlant Biotechnologies hit a milestone in the development of a regenerative dermal filler, and this achievement triggers a $10 million payment from AbbVie to CollPlant. In 2021, CollPlant and AbbVie entered into an exclusive worldwide development and commercializatio
- Cartessa Aesthetics Introduces Helix by DEKAhttps://modernaesthetics.com/news/cartessa-aesthetics-introduces-helix-by-deka/2473418/Cartessa Aesthetics is rolling out Helix by DEKA, a fractional ablative CO2 and non-ablative technologies in one device. The US is the first market to make HELIX commercially available. HELIX features pulse shape control for CoolPeel treatment and adds a 1570nm fiber lase
- Evolus Acquires Exclusive US Distribution Rights to Evolysse Line of Dermal Fillershttps://modernaesthetics.com/news/evolus-acquires-exclusive-us-distribution-rights-to-evolysse-line-of-dermal-fillers/2473412/Evolus has entered into a definitive agreement to be the exclusive US distributor of a line of five dermal fillers currently in late-stage development. Evolus is partnering with Symatese, a privately held French company, to introduce the Evolysse line to its US customers beginning
- Aquavit Files Investigational New Drug Application for Intradermal Dermatoxhttps://modernaesthetics.com/news/aquavit-files-investigational-new-drug-application-for-intradermal-dermatox/2473405/Aquavit has filed an Investigational New Drug Application with the U.S Food and Drug Administration (FDA) for Dermatox (aqubotulinumtoxinA), their intradermal injection of botulinum toxin. AqubotulinumtoxinA has already received regulatory approvals in Asia, Sou
- Exosome News: Elevai Labs Scores Grant to Better Characterize Stem Cell-derived Exosomeshttps://modernaesthetics.com/news/elevai-labs-scores-grant-to-better-characterize-stem-cell-derived-exosomes/2473403/Elevai Labs is partnering with Dr. Stanislav Sokolenko’s Lab at Dalhousie University in Nova Scotia, Canada to better characterize Elevai 's stem cell-derived exosomes thanks to a non-repayable grant from the Mitacs Accelerate Grants Program (“Mitacs”).
- Dermalogica Offers Digital Accreditation Badge for Beauty Proshttps://modernaesthetics.com/news/dermalogica-offers-digital-accreditation-badge-for-beauty-profs/2473391/Dermalogica is launching a new medispa accreditation for professional skin therapists. Launching April 17, 2023, the program aims to raise industry standards and provide more transparency to consumers. Unlike state board requirements that lead to esthetics licensing, the
- Establishment Labs Surpasses 3 Million Motiva Deviceshttps://modernaesthetics.com/news/establishment-labs-surpasses-3-million-motiva-devices/2473383/Establishment Labs Holdings announced that it has surpassed 3 million Motiva devices in market. The devices have been delivered to plastic and reconstructive surgeons since 2010 and are available in more than 85 countries. “Since its founding, Establishment Labs has been guid
- EON Robotic Body Contouring Device Gains Additional FDA Clearance for Back and Thighshttps://modernaesthetics.com/news/eon-robotic-body-contouring-device-gains-additional-fda-clearance-for-back-and-thighs/2473380/EON Smarter Body Contouring has received FDA clearance for the back and thighs—the third FDA clearance for EON. The device was previously FDA-cleared for clinical providers to treat patients' full abdomen and flanks. Parent company Dominion Aesthetic Technologies describe
- BTL Cracks Down on Counterfeit Devices in the U.S.https://modernaesthetics.com/news/btl-cracks-down-on-counterfeit-devices-in-the-us/2473373/BTL is making inroads in its efforts to safeguard medical providers and consumers from counterfeit devices in the United States through legal action and the seizure of illegally imported devices at the border. BTL has filed court documents stating that defendants use and sell knock
- Candela Receives Health Canada Licences for Nordlys Multi-Application System and Frax Pro Devicehttps://modernaesthetics.com/news/candela-receives-health-canada-licences-for-nordlys-multi-application-system-and-frax-pro-device/2473367/Candela announced Health Canada licensing and the availability of the Nordlys multi-application platform, which features Selective Waveband Technology (SWT) and the dual-wavelength Frax Pro non-ablative fractional laser platform.[1-4] The Nordlys is designed to improve treatme